21Jan 2020

PROGNOSTIC FACTORS AND FAILURE PATTERNS IN NON METASTATIC NASOPHARYNGEAL CARCINOMA AFTER VOLUMETRIC MODULATED ARC THERAPY, A RETROSPECTIVE STUDY

  • Radiotherapy Department, Mohammed V Military Teaching Hospital, Mohammed V University in Rabat, Morocco.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Purpose : The aim of this study was to identify the key failure patterns and prognostic factors of relapsed Nasopharyngeal carcinoma (NPC). Patients and Methods : Between January 2013 and December 2017, so during 5 years, a total of 101 patients with NPC were diagnosed and treated with radiotherapy (RT) or concurrent chemo radiotherapy at Military Teaching Hospital Mohamed V (MTHM V) of Rabat, Morocco. The sex ratio was 2,6 and the median age was 42,95?16,362 years. Regarding anatomo-pathological aspect, the undifferentiated carcinoma has been the most frequently, noticed in 93,1 %. The treatment received was based on neoadjuvant chemotherapy followed by concomitant chemo radiotherapy (RCC) in 79,2 % of patients, a RCC from the outset in 12,8 % of cases, and a neoadjuvant chemotherapy followed by radiotherapy in 8 % of cases. All patients were treated with VMAT technique with a prescribed doses levels of 69.96, 59.4 and 54 Gray in 33 sessions. Results : There were just 3 patients with incomplete follow-up, but complete follow-up information was available for 98 patients with a median follow-up time of 45,37 ? 17,31 months. The overall survival (OS) and the relapse free survival (RFS) rate after 5 years was 82,3 % and 76,8% respectively. Among the 101 patients, 21 (20,8 %) relapsed with the time to relapse was 22,6 ? 10,3 months. The loco regional relapse founded in 5 patients (5%) and metastases to the distant organ were found at 16 patients (15,8 %). Overall survival after 4 years of relapse changes according to seat of relapse. There OS at 4 years for locoregional relapse and for distant metastases was estimated at 83% and 7,3% respectively. Conclusion : This report reviews NPC recurrence data after primary treatment. Rates of local and distant relapse were comparable with those previously reported and the majority of recurrences occurred within the first five years. The prognosis after relapse varied with nodal status, seat of relapse as well as the remission duration after treatment.

  1. Blanchard P et al (2015). Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol; 16: 645-55
  2. No?l G and al (2002). Les traitements des cancers du nasopharynx : revue de la litt?rature. Cancer Radiother; 6: 59-84.
  3. Zhang MX et al (2015). Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up. Eur J Cancer: 587-95.
  4. Peyraga G et al (2016). Radioth?rapie des cancers des cavit?s nasosinusiennes. Cancer Radiother; 20: S99-103.
  5. Tao Xu md J et al (2013). Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge. Curr Oncol; 20(5), e406-419.
  6. Liu MZ et al (2008). Evaluation of sixth edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement. Int J Radiat Oncol Biol Phys; 70(4): 1115?23.
  7. Lee N et al (2009). Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009; 27(22): 3684?90.
  8. Ng WT et al (2011). Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys; 79 (2):420?8.
  9. Lu JJ et al (2010). Nasopharyngeal cancer multidisciplinary management. Medical radiology, diagnostic imaging and radiation oncology. Springer-verlag Berlin heidelberg.
  10. Zeng L (2014). Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China. Strahlenther Onkol; 190: 993?1000
  11. Li JX et al (2012). Clinical characteristics of recurrent nasopharyngeal carcinoma in high-incidence area. The Scientific World Journal; 719?54.
  12. Leung TW et al (2000). Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys; 48(5): 1331-8.
  13. Lee AW et al (1993). Retrospective ana-lysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence. Int J Radiat Oncol Biol Phys; 26: 773-82.
  14. Zheng X et al (2005). Dosimetric and clinical results of three-dimensional conformal radiotherapy for locally recurrent nasopharyngeal carcinoma. Radiother Oncol; 75: 197-203
  15. Leung TW et al (2000). Salvage radia-tion therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat OncolBiol Phys; 48: 1331-8.
  16. Li JX et al (2014). Local failure patterns forpatients with nasopharyngeal carcinoma after intensity-modulated radiothe-rapy. Radiat Oncol; 9: 87-94.
  17. Leung TW et al (2000). Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys; 48(5): 1331-8.
  18. Chua DT et al (1998). Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment. Int J Radiat Oncol Biol Phys; 41(2): 379-86.
  19. X Peng et al (2013). Clinical features and prognostic factors in patients with nasopharyngeal carcinoma relapse after primary treatment. Head Neck Oncol; 16; 5(2): 21.
  20. Yan‑Ping et al (2016). Prognostic factors and failure patterns in non‑metastatic nasopharyngeal carcinoma after intensity‑modulated radiotherapy Chin J Cancer; 35: 103
  21. Ng WT et al (2011). Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys; 79(2): 420-8.
  22. Lai SZ et al (2011). How does intensity modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys; 80(3): 661-8.
  23. Cheng SH et al (2001). Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy : impact on future clinical trials. Int J Radiat Oncol Biol Phys; 50 (3): 717-26.
  24. Lee AW et al (1999). Recurrent nasopharyngeal carcinoma: the puzzles of long latency. Int J Radiat Oncol Biol Phys; 44(1): 149-56.

[Khalid Hadadi, Maroa Belemlih, Mohcine Hommadi, Abdelhak Maghous, El-Amin Marnouch, K.A. Saghir, Mohamed Elmarjany, Hassan Sifat and Hamid Mansouri (2020); PROGNOSTIC FACTORS AND FAILURE PATTERNS IN NON METASTATIC NASOPHARYNGEAL CARCINOMA AFTER VOLUMETRIC MODULATED ARC THERAPY, A RETROSPECTIVE STUDY Int. J. of Adv. Res. 8 (Jan). 903-911] (ISSN 2320-5407). www.journalijar.com

Pr Hadadi Khalid
Radiation oncologist Military Teaching Hospital Med V, Rabat, Morrocco.

DOI:

Article DOI: 10.21474/IJAR01/10380      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10380

Download Full Paper

Download PDF No. of Downloads: 19 | No. of Views: 51